0001209191-18-022581.txt : 20180402
0001209191-18-022581.hdr.sgml : 20180402
20180402184621
ACCESSION NUMBER: 0001209191-18-022581
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180401
FILED AS OF DATE: 20180402
DATE AS OF CHANGE: 20180402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kewalramani Reshma
CENTRAL INDEX KEY: 0001735944
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18730788
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2018-04-01
2018-04-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001735944
Kewalramani Reshma
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP and CMO
Common Stock
4214
D
Stock Option (Right to Buy)
155.57
2028-02-05
Common Stock
8153
D
Includes a restricted stock unit award for 1,909 shares that vests in two equal installments on 2/17/2019 and 2/17/2020.
This Form 3/A is being filed to correct an error in the vesting schedule previously reported in the above footnote.
The option vests in 16 quarterly installments from 2/6/2018.
/s/ Stephen Migausky, Attorney-in-Fact
2018-04-02